Showing 1 - 10 of 11,380
Persistent link: https://www.econbiz.de/10011495052
pharmaceuticals, are deemed to be price inelastic with price elasticities of demand (PED) close to -0.20. However, most studies of PED … designed based on drug-specific incremental cost-effectiveness ratios, we estimate price elasticities of pharmaceuticals within … produce positive welfare effects. We estimate an overall PED for pharmaceuticals to be -0.16, close to the estimate of RAND …
Persistent link: https://www.econbiz.de/10012989727
pharmaceuticals, are deemed to be price inelastic with price elasticities of demand (PED) close to -0.20. However, most studies of PED … designed based on drug-specific incremental cost-effectiveness ratios, we estimate price elasticities of pharmaceuticals within … produce positive welfare effects. We estimate an overall PED for pharmaceuticals to be -0.16, close to the estimate of RAND …
Persistent link: https://www.econbiz.de/10012456367
Persistent link: https://www.econbiz.de/10009245334
This paper deals with the question how to model health effects after the cessation of a randomised controlled trial (RCT). Using clinical trial data on severe congestive heart failure patients we illustrate how survival beyond the cessation of a RCT can be predicted based on parametric survival...
Persistent link: https://www.econbiz.de/10001600068
Persistent link: https://www.econbiz.de/10000994775
Persistent link: https://www.econbiz.de/10013165112
Persistent link: https://www.econbiz.de/10012299936
Persistent link: https://www.econbiz.de/10012042417
Persistent link: https://www.econbiz.de/10011975485